Clinician-guided testosterone replacement therapy and enclomiphene for men — lab-based, individually evaluated, and monitored over time. Restore healthy testosterone the way it should be done: with real clinical oversight, not a checkbox.
Testosterone affects energy, body composition, mood, libido, and long-term metabolic health. Responsible hormone optimization starts with bloodwork to confirm clinically low testosterone, a clinician-designed protocol, and recurring labs to monitor your response over time. SEVEN is built around that standard.
Testosterone replacement therapy restores testosterone to a healthy physiological range in men with clinically low levels. SEVEN offers two clinician-determined pathways depending on your labs, symptoms, and goals.
Testosterone is the primary male sex hormone, central to muscle mass, fat distribution, energy, libido, mood, and aspects of metabolic health. Levels naturally decline with age, and some men develop clinically low testosterone (hypogonadism) with symptoms that affect daily life.
Direct testosterone therapy supplies the hormone itself — through injection, cream, or oral formulations — to restore levels into a healthy range under clinical supervision. It is the most established pathway for men with clearly low testosterone.
Enclomiphene is a non-steroidal alternative that stimulates the body's own testosterone production by acting on the pituitary. Because it works through your natural hormonal axis, it can help preserve endogenous production and fertility — a meaningful consideration for younger men or those planning to have children. A licensed clinician determines which pathway fits your situation.
TRT at SEVEN is part of a broader hormone and metabolic health platform and may be considered alongside other programs when clinically appropriate.
These symptoms are commonly associated with low testosterone, but they have many possible causes. Lab confirmation and clinician evaluation are required before any treatment. Individual results vary and outcomes are not guaranteed.
Persistent tiredness that does not improve with rest is one of the most commonly reported symptoms associated with low testosterone, though many factors can contribute.
Testosterone supports muscle protein synthesis. Difficulty building or maintaining muscle despite training can be associated with declining levels.
Testosterone is central to male sexual health. A noticeable decline in libido is a frequently reported symptom that warrants clinical evaluation.
Shifts in body composition, particularly increased abdominal fat, can be associated with hormonal changes and metabolic factors.
Mood changes, irritability, and reduced concentration are sometimes associated with low testosterone, though these symptoms are non-specific.
Disrupted sleep and slower physical recovery can accompany hormonal decline and are evaluated as part of a comprehensive clinical picture.
These symptoms have many possible causes and are not diagnostic of low testosterone. A licensed clinician evaluates your labs and health history before determining whether treatment is appropriate. Individual results vary and are not guaranteed. Read more: Signs of Low Testosterone →
Complete the early access form at getmyseven.com. Initial onboarding will be limited — join now to secure your spot.
Complete a detailed online health intake and baseline bloodwork. Lab work is required so a clinician can confirm clinically low testosterone and rule out contraindications. Labs are coordinated through SEVEN's clinical infrastructure.
A licensed clinician reviews your labs and intake in a scheduled visit, discusses your goals, and determines whether testosterone therapy or enclomiphene is clinically appropriate for you.
If approved, your provider designs an individualized protocol. Medication is coordinated through SEVEN and shipped directly to your door with clear administration guidance.
TRT is not set-and-forget. Recurring labs and provider check-ins monitor your response, track safety markers, and allow your protocol to be adjusted over time.
Eligibility is determined by a licensed clinician following lab work and individual health intake review. The following reflects general clinical considerations.
Direct testosterone therapy is currently available to men 25 and older; enclomiphene is available to men 18 and older. Age criteria are subject to change and confirmed at intake.
Treatment requires bloodwork confirming clinically low testosterone. Lab confirmation is a prerequisite, not an optional step.
Men who wish to preserve natural production or fertility may be candidates for enclomiphene rather than direct testosterone, at clinician discretion.
Certain conditions are contraindications for testosterone therapy. These are reviewed during the clinical intake and lab evaluation process.
Treatment eligibility is determined exclusively by a licensed clinician following review of your labs and individual health intake. This is not a guarantee of treatment approval. Direct testosterone therapy is currently available to men 25 and older in a subset of states; enclomiphene is available to men 18 and older in all 50 states plus D.C. Availability and age criteria are subject to change based on regulatory requirements.